NCT02470494View on ClinicalTrials.gov

The EarLens Contact Hearing Device (CHD) Spectrum Study

NACompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

June 30, 2016

Study Completion Date

November 30, 2016

Conditions
Hearing Loss, Sensorineural
Interventions
DEVICE

Sound amplification provided via the EarLens CHD

Subjects with mild to severe hearing impairment receiving sound amplification treatment with EarLens CHD.

Trial Locations (8)

15212

Pittsburgh Ear Associates, Pittsburgh

27609

Carolina Ear and Hearing Clinic, Raleigh

52242

University of Iowa, Iowa City

70072

CNC Hearing and Balance Center, Marrero

78240

Ear Medical Group, San Antonio

92037

California Hearing and Balance Center, La Jolla

94025

Rodney Perkins Associates, Menlo Park

95138

Camino Ear Nose and Throat Clinic, San Jose

Sponsors
All Listed Sponsors
lead

EarLens Corporation

INDUSTRY